-
公开(公告)号：US20130204002A1
公开(公告)日：2013-08-08
申请号：US13638399
申请日：2011-03-29
Applicant: Anu Mittal , Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
Inventor： Anu Mittal , Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
IPC: C07D401/12
CPC classification number: C07D401/12
Abstract: The present invention relates to a process for the preparation of crystalline dexlansoprazole.
Abstract translation: 本发明涉及一种制备结晶右兰索拉唑的方法。
-
Patent Agency Ranking
公开(公告)号：US09085556B2
公开(公告)日：2015-07-21
申请号：US13638310
申请日：2011-03-29
Applicant: Anu Mittal , Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
Inventor： Anu Mittal , Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
IPC: C07D401/12
CPC classification number: C07D401/12
Abstract: The present invention relates to the salts of dexlansoprazole in amorphous form. The present invention further relates to processes for the preparation of salts of dexlansoprazole.
Abstract translation: 本发明涉及无定形形式的右兰索拉唑盐。 本发明还涉及右兰索拉唑盐的制备方法。
-
公开(公告)号：US08853411B2
公开(公告)日：2014-10-07
申请号：US13638399
申请日：2011-03-29
Applicant: Anu Mittal , Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
Inventor： Anu Mittal , Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
IPC: C07D401/12
CPC classification number: C07D401/12
Abstract: The present invention relates to a process for the preparation of crystalline dexlansoprazole.
Abstract translation: 本发明涉及一种制备结晶右兰索拉唑的方法。
-
4.发明申请公开(公告)号：US20130197232A1
公开(公告)日：2013-08-01
申请号：US13574849
申请日：2011-01-28
Applicant: Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
Inventor： Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
IPC: C07D401/12
CPC classification number: C07D401/12
Abstract: The present invention relates to crystalline forms of dexlansoprazole designated as forms A and B, and their preparation. The present invention further relates to processes for the preparation of anhydrous dexlansoprazole and dexlansoprazole sesquihydrate using crystalline Forms A and B of dexlansoprazole.
Abstract translation: 本发明涉及称为形式A和B的右兰索拉唑的结晶形式及其制备方法。 本发明还涉及使用右兰索拉唑的晶型A和B制备无水右兰索拉唑和右兰索拉唑倍半水合物的方法。
-
公开(公告)号：US20130197233A1
公开(公告)日：2013-08-01
申请号：US13638310
申请日：2011-03-29
Applicant: Anu Mittal , Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
Inventor： Anu Mittal , Anmol Kumar Ray , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad
IPC: C07D401/12
CPC classification number: C07D401/12
Abstract: The present invention relates to the salts of dexlansoprazole in amorphous form. The present invention further relates to processes for the preparation of salts of dexlansoprazole.
Abstract translation: 本发明涉及无定形形式的右兰索拉唑盐。 本发明还涉及右兰索拉唑盐的制备方法。
-
公开(公告)号：US20140357870A1
公开(公告)日：2014-12-04
申请号：US14127680
申请日：2012-06-20
Applicant: Anmol Kumar Ray , Anu Mittal , Nagaraju Gottumukkala , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad , Sudershan Kumar Arora
Inventor： Anmol Kumar Ray , Anu Mittal , Nagaraju Gottumukkala , Mahavir Singh Khanna , Rajesh Kumar Thaper , Mohan Prasad , Sudershan Kumar Arora
IPC: C07D401/12
CPC classification number: C07D401/12
Abstract: The present invention relates to a process for the preparation of dexlansoprazole.xH2O, wherein x is about 0.0 to about 0.1, using dexlansoprazole.xH2O, wherein x is about 2.6 to about 50.
Abstract translation: 本发明涉及使用右兰索拉唑×H 2 O制备右兰索拉唑×H 2 O的方法，其中x为约0.0至约0.1，其中x为约2.6至约50。
-
-
-
-
-
Search Results
6
records
(took 0.008 seconds)
